| The industry’s heading to Las Vegas next month.  | The industry’s heading to Las Vegas next month.
Cannabis Conference is thrilled to announce the most recent additions to our speaker line-up!
This year, four executives from DNA Genetics — one of the most recognized and awarded cannabis companies in the world — will be sharing their valuable insights from decades of experience in the cannabis industry, April 21-23, at Paris Las Vegas.
DNA Genetics’ wide genetic library has been licensed around the globe, including with major cannabis companies such as Canada’s Canopy Growth Corp. DNA Genetics is also actively engaged in genetic research, developing high THC varieties and high CBD varieties, as well as other unique and valuable cannabinoid and terpene profiles that have been recognized in scientific communities as having high medical value in an effort to isolate and standardize their efficacy.
Join us in Vegas for the opportunity to learn from these esteemed experts in breeding, cultivation and marketing: |
|  | DONALD MORRIS
Co-Founder and Chief Research Officer, DNA Genetics |
|
 | AARON YARKONI
Co-Founder and Chief Research Officer, DNA Genetics |
|
|
| | Don and Aaron (“D” and “A”) founded DNA Genetics in Amsterdam in 2004. At the time, Amsterdam was the only market that provided for legal commercial cannabis activity, so they decided to bring their award-winning California genetics to the European marketplace for the first time. After over a decade building the brand in Europe and developing strategic partnerships throughout the world, DNA began entering each legal market, allowing for specialized breeding through carefully refined proprietary selection processes. In doing so, DNA built an extensive library of valuable genetics that are the foundation for many award-winning varieties and cannabinoid profiles for medical and adult-use applications. |
|  |  CHARLES PHILLIPS
CEO, DNA Genetics
Charles Phillips is the CEO of DNA Genetics. Phillips began his career as an Associate at The Boston Consulting Group, received his Bachelor’s Degree in Government from Harvard University, and his Master of Business Administration from Stanford Graduate School of Business. He ran business development from 2017-18 at Harborside Health, a major cannabis retailer in Oakland, before joining DNA Genetics. |
| |  REZWAN KHAN
Vice President of Global Corporate Development, DNA Genetics
Rezwan Khan is the Vice President of Global Corporate Development at DNA Genetics. Since 2006, he has guided the company’s brand strategy, including negotiating a global licensing partnership with Canopy Growth Corporation. Khan is also co-founder of seedleSs, a cannabis counterculture brand and marketing firm. Khan is an expert in comparative cannabis law with over 20 years of experience in cannabis brand development, marketing, licensing, cultivation, manufacturing, retail and supply-chain management. He recently was elected President of the Global Alliance for Cannabis Commerce, a trade organization representing over a billion dollars of global cannabis market share. He received his bachelor’s degree in Psychology from San Diego State University and Juris Doctor from the Thomas Jefferson School of Law. |
| Register today to meet and learn from these and other speakers at Cannabis Conference 2020! |
| | | | | |
| This is a conference email brought to you by Cannabis Conference.
Unsubscribe from this email.
Manage Email Preferences
GIE Media, Inc. • 5811 Canal Road • Valley View, OH 44125 |
|
